Researchers have developed CRISP, a cutting-edge computational framework enabling prediction of drug-induced perturbation responses at single-cell resolution across previously untested cell types. This AI-driven approach addresses a critical challenge in drug repurposing by forecasting therapeutic efficacy and cellular responses, facilitating precision medicine and streamlining drug development processes. The study introduces a versatile tool empowering more accurate and scalable drug response analyses.